Key Takeaways
- • California Governor Gavin Newsom signed Assembly Bill 1415 (AB 1415) and Senate Bill 351 (SB 351) on October 11, 2025, with both laws taking effect January 1, 2026, fundamentally expanding state oversight of private equity and hedge fund activity in healthcare.
- • AB 1415 expands the Office of Health Care Affordability's (OHCA) jurisdiction to require private equity groups, hedge funds, management services organizations (MSOs), and entities that own or control healthcare providers to file transaction notices, creating a 90-day pre-close review process for covered deals.
- • The legislation mandates OHCA collection and analysis of data on private equity and hedge fund involvement in healthcare to assess their impact on cost, quality, access, and market consolidation—signaling California's heightened scrutiny of financial entity influence on provider networks.
- • SB 351 prohibits private equity groups and hedge funds from interfering with clinical judgment or exercising impermissible control over physician and dental practices operating in California, establishing guardrails on operational authority.
- • Healthcare stakeholders and deal advisors must now integrate OHCA notification requirements and extended review timelines into transaction structuring for ownership changes, mergers, acquisitions, and MSO arrangements, increasing compliance complexity and deal timelines in the nation's largest state healthcare market.
Summary
California has enacted sweeping regulatory changes aimed at constraining private equity and hedge fund influence in healthcare. Governor Newsom signed AB 1415 and SB 351 into law on October 11, 2025, with implementation beginning January 1, 2026. These measures represent a material escalation in state-level scrutiny of alternative capital participation in the healthcare sector and establish precedent that may influence regulatory approaches in other jurisdictions.
AB 1415 substantially expands the mandate of the Office of Health Care Affordability by requiring private equity groups, hedge funds, MSOs, and entities that own, operate, or control healthcare providers to file transaction notices with OHCA prior to closing. This notification framework covers ownership and control changes, mergers, acquisitions, and MSO arrangements, regardless of whether the provider is currently operating. The law grants OHCA authority to collect granular data on these entities and analyze their role in healthcare cost dynamics, quality outcomes, access, and market consolidation patterns. The 90-day pre-close filing requirement creates an extended review window that will materially impact transaction timeline planning and deal certainty for PE and hedge fund investors.
SB 351 establishes behavioral restrictions on private equity and hedge fund involvement in physician and dental practices. The statute prohibits these financial entities from interfering with professional judgment or exercising impermissible control over clinical decision-making by practitioners in California. This provision reflects legislative concern that financial optimization objectives may conflict with patient-centered care standards and professional autonomy.
For institutional investors and alternative asset managers, these laws necessitate immediate operational adjustments. Healthcare transaction structures must now account for OHCA review processes, expanded notice requirements, and extended closing timelines. The data collection mandate signals California's intent to build an empirical record on PE and hedge fund impact in healthcare markets, potentially informing future legislative or regulatory action. Deal advisors, legal counsel, and investment teams must integrate compliance with both statutes into transaction feasibility assessments and investment decision frameworks across the California healthcare market.
AB 1415 substantially expands the mandate of the Office of Health Care Affordability by requiring private equity groups, hedge funds, MSOs, and entities that own, operate, or control healthcare providers to file transaction notices with OHCA prior to closing. This notification framework covers ownership and control changes, mergers, acquisitions, and MSO arrangements, regardless of whether the provider is currently operating. The law grants OHCA authority to collect granular data on these entities and analyze their role in healthcare cost dynamics, quality outcomes, access, and market consolidation patterns. The 90-day pre-close filing requirement creates an extended review window that will materially impact transaction timeline planning and deal certainty for PE and hedge fund investors.
SB 351 establishes behavioral restrictions on private equity and hedge fund involvement in physician and dental practices. The statute prohibits these financial entities from interfering with professional judgment or exercising impermissible control over clinical decision-making by practitioners in California. This provision reflects legislative concern that financial optimization objectives may conflict with patient-centered care standards and professional autonomy.
For institutional investors and alternative asset managers, these laws necessitate immediate operational adjustments. Healthcare transaction structures must now account for OHCA review processes, expanded notice requirements, and extended closing timelines. The data collection mandate signals California's intent to build an empirical record on PE and hedge fund impact in healthcare markets, potentially informing future legislative or regulatory action. Deal advisors, legal counsel, and investment teams must integrate compliance with both statutes into transaction feasibility assessments and investment decision frameworks across the California healthcare market.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.